LIFR Antikörper (C-Term)

Produktnummer ABIN6243802

Produktdetails anti-LIFR Antikörper

Target: LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))

Bindungsspezifität: AA 1021-1055, C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LIFR Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This LIFR antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1021-1055 amino acids from the C-terminal region of human LIFR.

Klon: RB51633

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000. WB: 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Details zu LIFR

Target: LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))

Andere Bezeichnung: LIFR (LIFR Produkte)

Synonyme: A230075M04Rik antikoerper, AW061234 antikoerper, LIF antikoerper, CD118 antikoerper, LIF-R antikoerper, SJS2 antikoerper, STWS antikoerper, SWS antikoerper, leukemia inhibitory factor receptor antikoerper, LIF receptor alpha antikoerper, leukemia inhibitory factor receptor alpha antikoerper, Lifr antikoerper, LOC397451 antikoerper, LIFR antikoerper

Hintergrund: Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells.

Molekulargewicht: 123743

UniProt: P42702

Pathways: JAK-STAT Signalweg, Growth Factor Binding